186 related articles for article (PubMed ID: 37861747)
1. RFC3 serves as a novel prognostic biomarker and target for head and neck squamous cell carcinoma.
Avs KR; Pandi C; Kannan B; Pandi A; Jayaseelan VP; Arumugam P
Clin Oral Investig; 2023 Nov; 27(11):6961-6969. PubMed ID: 37861747
[TBL] [Abstract][Full Text] [Related]
2. Triggering receptor expressed in myeloid cells 1 (TREM1) as a potential prognostic biomarker and association with immune infiltration in oral squamous cell carcinoma.
Kannan B; Pandi C; Pandi A; Jayaseelan VP; Arumugam P
Arch Oral Biol; 2024 May; 161():105926. PubMed ID: 38442472
[TBL] [Abstract][Full Text] [Related]
3. Alteration in PNMA1 expression is associated with poor prognosis and tumor immune infiltration in head and neck squamous cell carcinoma.
Sankar D; Kannan B; Jayaseelan VP; Manicka Vasagam J; Arumugam P
J Oral Biol Craniofac Res; 2024; 14(1):1-7. PubMed ID: 38075236
[TBL] [Abstract][Full Text] [Related]
4. Increased SEC14L2 expression is associated with clinicopathological features and worse prognosis in oral squamous cell carcinoma.
David JJ; Kannan B; Pandi C; Jayaseelan VP; Vasagam JM; Arumugam P
Odontology; 2024 Apr; ():. PubMed ID: 38575815
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and clinicopathological significance of MRC2 expression in head and neck squamous cell carcinoma.
Gopalakrishnan KV; Kannan B; Pandi C; Jayaseelan VP; Arumugam P
J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101617. PubMed ID: 37666484
[TBL] [Abstract][Full Text] [Related]
6.
Chen L; Lin J; Lan B; Xiong J; Wen Y; Chen Y; Chen CB
Comput Math Methods Med; 2022; 2022():5851755. PubMed ID: 36510584
[TBL] [Abstract][Full Text] [Related]
7. FAM3 Family as Prognostic Factors for Head and Neck Squamous Cell Carcinoma.
Liao C; Wang Q; An J; Wang H; Xiao L; Long Q; Zhao H; Liu J; Guan X
Comb Chem High Throughput Screen; 2023; 26(3):539-558. PubMed ID: 35538834
[TBL] [Abstract][Full Text] [Related]
8. EXT2: a novel prognostic and predictive biomarker for head and neck squamous cell carcinoma.
Selvan AJA; Kannan B; Pandi C; Jayaseelan VP; Arumugam P
Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 Mar; 137(3):282-289. PubMed ID: 38155009
[TBL] [Abstract][Full Text] [Related]
9. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
[TBL] [Abstract][Full Text] [Related]
10. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
Yang L; Lu P; Yang X; Li K; Chen X; Qu S
Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
[TBL] [Abstract][Full Text] [Related]
11. DOCK8 Serves as a Prognostic Biomarker and Is Related to Immune Infiltration in Patients With HPV Positive Head and Neck Squamous Cell Carcinoma.
Zhang Z; Bao Y; Zhou L; Ye Y; Fu W; Sun C
Cancer Control; 2021; 28():10732748211011951. PubMed ID: 33910393
[TBL] [Abstract][Full Text] [Related]
12. HtrA3: a promising prognostic biomarker and therapeutic target for head and neck squamous cell carcinoma.
Chen Y; Yang J; Jin H; Wen W; Xu Y; Zhang X; Wang Y
PeerJ; 2023; 11():e16237. PubMed ID: 37842043
[TBL] [Abstract][Full Text] [Related]
13. High eukaryotic initiation factor 5A2 expression predicts poor prognosis and may participate in the SNHG16/miR-10b-5p/EIF5A2 regulatory axis in head and neck squamous cell carcinoma.
Ye S; Wang D; Jin M; Du J; Chen X; Zhang H; Zhou C; Fang S; Liu K
J Clin Lab Anal; 2023 Jan; 37(1):e24820. PubMed ID: 36550070
[TBL] [Abstract][Full Text] [Related]
14. CERCAM is a prognostic biomarker associated with immune infiltration of macrophage M2 polarization in head and neck squamous carcinoma.
Yang Y; Yan C; Chen XJ
BMC Oral Health; 2023 Oct; 23(1):724. PubMed ID: 37803318
[TBL] [Abstract][Full Text] [Related]
15. E2F4 transcription factor is a prognostic biomarker related to immune infiltration of head and neck squamous cell carcinoma.
Qi L; Ren Z; Li W
Sci Rep; 2022 Jul; 12(1):12132. PubMed ID: 35840663
[TBL] [Abstract][Full Text] [Related]
16. Elevated expression of iASPP in head and neck squamous cell carcinoma and its clinical significance.
Liu Z; Zhang X; Huang D; Liu Y; Zhang X; Liu L; Li G; Dai Y; Tan H; Xiao J; Tian Y
Med Oncol; 2012 Dec; 29(5):3381-8. PubMed ID: 22815155
[TBL] [Abstract][Full Text] [Related]
17. Notch Signaling Activation Is Associated with Patient Mortality and Increased FGF1-Mediated Invasion in Squamous Cell Carcinoma of the Oral Cavity.
Weaver AN; Burch MB; Cooper TS; Della Manna DL; Wei S; Ojesina AI; Rosenthal EL; Yang ES
Mol Cancer Res; 2016 Sep; 14(9):883-91. PubMed ID: 27353029
[TBL] [Abstract][Full Text] [Related]
18. Identification of increased NBS1 expression as a prognostic marker of squamous cell carcinoma of the oral cavity.
Hsu DS; Chang SY; Liu CJ; Tzeng CH; Wu KJ; Kao JY; Yang MH
Cancer Sci; 2010 Apr; 101(4):1029-37. PubMed ID: 20175780
[TBL] [Abstract][Full Text] [Related]
19. Exploring the Expression of BCAS3 in Head and Neck Squamous Cell Carcinoma and Its Association With Prognosis.
Challa D; Pandi C; Kannan B; Priyadharsini VJ; Arumugam P
Cureus; 2023 Dec; 15(12):e50995. PubMed ID: 38259392
[TBL] [Abstract][Full Text] [Related]
20. Identification of HOXB9 based on comprehensive bioinformatics analysis for predicting prognosis of head and neck squamous cell carcinoma.
Li J; Ran H; Zeng X; Yang D; Zeng X; Zhang P
Medicine (Baltimore); 2023 Sep; 102(35):e35035. PubMed ID: 37657018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
